Localised erythema nodosum leprosum-A rare entity managed with thalidomide
Abstract Leprosy is caused by Mycobacterium leprae. The condition primarily affects the skin and peripheral nerves. There are two types of leprosy reactions, Type 1 and Type 2 or erythema nodosum leprosum (ENL). ENL is a severe multi‐system, immune‐mediated complication of lepromatous leprosy. It is...
Saved in:
Main Authors: | Chandni Patel (Author), Barbara De Barros (Author), Stephen L. Walker (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
T-cell regulation in Erythema Nodosum Leprosum.
by: Edessa Negera, et al.
Published: (2017) -
Etanercept in erythema nodosum leprosum
by: Julia Rocha Silva Santos, et al.
Published: (2017) -
Management of erythema nodosum leprosum by mycophenolate mofetil
by: Banerjee Kalyan, et al.
Published: (2008) -
The Use of Thalidomide in Steroid Dependent Continous Erythema Nodosum Leprosum Leprosy Patient: A Case Report
by: Dian Pertiwi Habibie, et al.
Published: (2016) -
Complement C1q expression in Erythema nodosum leprosum.
by: Edessa Negera, et al.
Published: (2018)